Holen Sie sich die Stockscreener-App
17.25
0.29%
-0.05
Handel nachbörslich:
17.47
0.22
+1.28%
Schlusskurs vom Vortag:
$17.30
Offen:
$17.16
24-Stunden-Volumen:
1.32M
Relative Volume:
0.96
Marktkapitalisierung:
$851.56M
Einnahmen:
$224.45M
Nettoeinkommen (Verlust:
$-95.27M
KGV:
-8.9378
EPS:
-1.93
Netto-Cashflow:
$-43.74M
1W Leistung:
-1.65%
1M Leistung:
-22.02%
6M Leistung:
-36.81%
1J Leistung:
-21.16%
1-Tages-Spanne:
$16.62
$17.66
1-Wochen-Bereich:
$16.62
$17.73
52-Wochen-Spanne:
$13.50
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Firmenname
Staar Surgical Co
Sektor
Telefon
(626) 303-7902
Adresse
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
17.25 | 854.03M | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
496.12 | 175.84B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
180.62 | 48.87B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.39 | 39.53B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.62 | 38.39B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
45.04 | 37.69B | 27.43B | 1.27B | 1.01B | 1.5829 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-03 | Eingeleitet | Wedbush | Neutral |
| 2026-01-16 | Fortgesetzt | Morgan Stanley | Underweight |
| 2025-04-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-02-12 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-02-12 | Herabstufung | Jefferies | Buy → Hold |
| 2025-02-12 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-03-11 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-05 | Herabstufung | Needham | Buy → Hold |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-02-06 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-12-28 | Bestätigt | BTIG Research | Buy |
| 2022-12-08 | Eingeleitet | Stifel | Hold |
| 2022-11-07 | Hochstufung | Sidoti | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-28 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-07-09 | Eingeleitet | Oppenheimer | Perform |
| 2021-01-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-08-31 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-08-06 | Bestätigt | The Benchmark Company | Buy |
| 2020-07-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-06-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-06-15 | Eingeleitet | Jefferies | Buy |
| 2019-12-04 | Eingeleitet | BTIG Research | Buy |
| 2018-09-24 | Bestätigt | The Benchmark Company | Buy |
| 2018-08-06 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-11-20 | Bestätigt | The Benchmark Company | Buy |
| 2017-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2017-03-03 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Fortgesetzt | The Benchmark Company | Buy |
| 2013-02-28 | Bestätigt | The Benchmark Company | Buy |
| 2012-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Eingeleitet | Northland Securities | Outperform |
| 2011-10-25 | Bestätigt | The Benchmark Company | Buy |
| 2010-10-12 | Eingeleitet | Morgan Joseph | Buy |
| 2010-05-11 | Eingeleitet | Benchmark | Buy |
Alle ansehen
Staar Surgical Co Aktie (STAA) Neueste Nachrichten
VIEW Optometry launches to support independent practices - Eyes On Eyecare
STAAR Surgical Company (NASDAQ:STAA) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
212,421 Shares in STAAR Surgical Company $STAA Acquired by Versor Investments LP - MarketBeat
Eli Lilly To Rally More Than 21%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
STAAR Surgical (NASDAQ:STAA) Given New $19.00 Price Target at Stifel Nicolaus - MarketBeat
Staar Surgical price target lowered to $19 from $28 at Stifel - TipRanks
Leadership watch: Staar Surgical names co-CEOs, ACET adds to Board - Eyes On Eyecare
STAAR Surgical stock price target lowered to $19 by Stifel on China concerns By Investing.com - Investing.com India
STAAR Surgical stock price target lowered to $19 by Stifel on China concerns - Investing.com Nigeria
1 Cash-Heavy Stock on Our Watchlist and 2 We Brush Off - Finviz
Staar Surgical CoEnters agreement with Chief Legal Officer Nathaniel SisitskySEC filing - marketscreener.com
STAAR Surgical Company (STAA): A Bull Case Theory - Finviz
Staar Surgical initiated with a Neutral at Wedbush - TipRanks
STAAR Surgical sinks as it plans to terminate sale to Alcon (update) - MSN
Staar Surgical (STAA) to Report Q4 Results: Wall Street Expects Earnings Growth - Finviz
STAA Receives Neutral Rating as Wedbush Initiates Coverage | STA - GuruFocus
STAAR names interim co-CEOs amid search for permanent leader - MedTech Dive
STAAR Surgical (NASDAQ:STAA) Now Covered by Wedbush - MarketBeat
STAAR Surgical (STAA) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
STAAR Surgical Names Warren Foust and Deborah Andrews Interim Co-CEOs - VisionMonday.com
Why STAAR Surgical (STAA) stock is trading lower today - MSN
Staar Surgical names interim co-CEOs in leadership shift following failed Alcon deal - MassDevice
Why STAAR Surgical (STAA) Shares Are Down Today - Bitget
Why STAAR Surgical (STAA) Stock Is Trading Lower Today - Finviz
Staar Surgical Appoints Interim Co-CEOs - Orange County Business Journal
STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs - PharmiWeb.com
New weekly contact lens offers Canadians 16 hours of daily comfort - stocktitan.net
Staar Surgical appoints Warren Foust & Deborah Andrews interim co-CEOs - marketscreener.com
STAAR Surgical Company Announces Interim Co-CEO Appointments, Effective February 1, 2026 - marketscreener.com
Staar Surgical (STAA) Appoints Interim Co-CEOs as CEO Search Beg - GuruFocus
A month after Alcon deal fell through, Staar Surgical searches for next CEO and names interim leaders - Fierce Biotech
Staar Surgical Names Interim Co-CEOs Amid Leadership Transition - TipRanks
Staar Surgical appoints COO Warren Foust, CFO Deborah Andrews as interim co-CEOs - TipRanks
STAAR Surgical Company (STAA) Stock Analysis: Insights Into The 23.34% Potential Upside - DirectorsTalk Interviews
Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems - Benzinga
Assessing Staar Surgical: Insights From 4 Financial Analysts - Benzinga
Jefferies Lowers Staar Surgical (STAA) Price Target to $21.50 | STAA Stock News - GuruFocus
Jefferies Lowers Staar Surgical (STAA) Price Target to $21.50 | - GuruFocus
Jefferies Financial Group Lowers STAAR Surgical (NASDAQ:STAA) Price Target to $21.50 - MarketBeat
Alcon announces purchase of STARR Surgical for $1.5 billion - MSN
The Truth About STAAR Surgical Co: The Tiny Eye Stock Chasing a Massive Glow-Up - AD HOC NEWS
Analysts Question STAAR Surgical Company (STAA)'s Post-Merger Standalone Valuation - Finviz
Analysts Question STAAR Surgical Company (STAA)’s Post-Merger Standalone Valuation - Insider Monkey
The Truth About STAAR Surgical Co: Is This Eye Tech Stock About To Blow Up Or Black Out? - AD HOC NEWS
Is STAAR Surgical (STAA) Attractively Priced After Prolonged Share Price Weakness? - simplywall.st
Staar Surgical, Dynatrace, and More Stocks See Action From Activist Investors -- Barrons.com - 富途牛牛
STAAR Surgical Company (STAA) Investor Outlook: Assessing The 21% Potential Upside - DirectorsTalk Interviews
Eye-care giant Alcon spends $750M buying back its own stock - Stock Titan
Staar Surgical Terminates $1.6B Sale to Alcon - Orange County Business Journal
Implantable Collamer Lens (ICL) Market to Reach USD 810 Million - openPR.com
Why STAAR Surgical (STAA) Is Down 5.2% After Shareholders Reject Alcon Deal And Board Power Shifts - Yahoo Finance UK
Finanzdaten der Staar Surgical Co-Aktie (STAA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.28%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):